Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 52,854,480 | 47,921,880 | 50,266,340 | 47,821,850 | 46,347,940 |
| Cost of Goods | 14,763,640 | 14,289,130 | 15,407,620 | 14,429,050 | 14,498,890 |
| Gross Profit | 38,090,840 | 33,632,750 | 34,858,720 | 33,392,800 | 31,849,050 |
| Operating Expenses | 28,260,750 | 25,413,250 | 25,265,840 | 22,672,470 | 22,004,180 |
| Operating Income | 9,830,730 | 8,219,629 | 9,593,504 | 10,720,380 | 9,845,758 |
| Interest Expense | 636,978 | 1,161,093 | 1,421,060 | 463,584 | 435,381 |
| Other Income | -2,382,724 | 254,296 | -555,217 | 795,469 | -138,423 |
| Pre-tax Income | 6,811,028 | 7,312,832 | 7,617,228 | 11,052,265 | 9,271,954 |
| Income Tax | 1,180,050 | 1,302,848 | 1,733,845 | 2,113,521 | 1,843,270 |
| Net Income Continuous | 5,630,978 | 6,009,983 | 5,883,383 | 8,938,742 | 7,428,685 |
| Net Income Discontinuous | 3,251,644 | 69,254 | N/A | N/A | N/A |
| Minority Interests | 42,993 | 62,762 | 38,963 | 119,057 | 66,254 |
| Net Income | $8,839,628 | $6,016,476 | $5,844,420 | $8,819,686 | $7,362,432 |
| EPS Basic Total Ops | 3.62 | 2.40 | 2.33 | 3.52 | 2.94 |
| EPS Basic Continuous Ops | 2.31 | 2.40 | 2.35 | 3.57 | 2.97 |
| EPS Basic Discontinuous Ops | 1.33 | 0.03 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 3.60 | 2.40 | 2.33 | 3.51 | 2.93 |
| EPS Diluted Continuous Ops | 2.30 | 2.39 | 2.34 | 3.56 | 2.95 |
| EPS Diluted Discontinuous Ops | 1.33 | 0.03 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 4.43 | 3.85 | 4.39 | 4.35 | 3.88 |
| EBITDA(a) | $16,254,820 | $12,100,040 | $14,779,890 | $14,323,690 | $13,810,330 |